Revance Therapeutics Inc (RVNC)

[iwfal]

No one will get rock bottom price when all things are lined up. Investing in RVNC is taking on some risk, probably higher risk than many can handle. So I won’t suggest my grandma to go all in this name.

Yes, the drug itself seems pretty likely to, eventually, take over the market. But that avails current shareholders little if they’ve diluted, say, 2:1 in order to get there. And that seems quite possible at this point as stock price continues to drop, and cash disappears with no apparent reliable plan to halt cash burn.

Eg drops to 2, Foley realizes he can’t make it to positive EBITA, raises another $100M - about 2 quarters. Ie About a 30% dilution. Then, 2 quarters later, at 1.5 another 70m. Another 30% dilution. Etc.